ResMed Inc. (RMD) To Go Ex-Dividend on August 20th

ResMed Inc. (NYSE:RMD) declared a quarterly dividend on Thursday, August 6th. Stockholders of record on Thursday, August 20th will be given a dividend of 0.66 per share by the medical equipment provider on Thursday, September 24th. This represents a c) dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Thursday, August 20th. This is a 10.0% increase from ResMed’s previous quarterly dividend of $0.60.

ResMed has raised its dividend payment by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 13 years. ResMed has a dividend payout ratio of 25.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect ResMed to earn $13.10 per share next year, which means the company should continue to be able to cover its $2.64 annual dividend with an expected future payout ratio of 20.2%.

ResMed Stock Down 1.8%

RMD opened at $220.37 on Tuesday. The firm’s fifty day moving average price is $204.54 and its two-hundred day moving average price is $220.64. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.10 and a quick ratio of 2.42. The company has a market capitalization of $31.97 billion, a P/E ratio of 21.13, a P/E/G ratio of 1.41 and a beta of 0.76. ResMed has a fifty-two week low of $180.26 and a fifty-two week high of $293.81.

ResMed (NYSE:RMD) last issued its quarterly earnings data on Thursday, August 6th. The medical equipment provider reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.89 by $0.06. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.46 billion. ResMed had a return on equity of 25.58% and a net margin of 26.94%.The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.55 EPS. On average, analysts anticipate that ResMed will post 12.03 EPS for the current year.

ResMed Company Profile

ResMed (NYSE: RMD) is a global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions. Founded in 1989, the company is headquartered in San Diego, California, and develops, manufactures and distributes a range of devices and software used by patients, clinicians and providers worldwide.

ResMed’s product portfolio centers on noninvasive ventilation and sleep therapy equipment, including continuous positive airway pressure (CPAP) and bilevel devices, masks and related accessories for the treatment of obstructive sleep apnea and other respiratory disorders.